共 32 条
[1]
Kokudo T(2016)Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion J Hepatol 65 938-943
[2]
Chan SL(2014)International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study Chin J Cancer 33 481-491
[3]
Bruix J(2011)Management of hepatocellular carcinoma: an update Hepatology 53 1020-1022
[4]
Sherman M(2012)EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 908-943
[5]
Jeong SW(2013)Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis Gut Liver 7 696-703
[6]
do Song S(2015)A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis J Gastroenterol 50 445-454
[7]
Zhang Y(2015)Sorafenib with and without transarterial chemoembolization for advanced hepatocellular carcinoma with main portal vein tumor thrombosis: a retrospective analysis Oncologist 20 1417-1424
[8]
Ikeda M(2016)Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial Ann Oncol 27 2090-2096
[9]
Ueshima K(2015)Phase I/II study of sorafenib in combination with hepatic arterial infusion chemotherapy using low-dose cisplatin and 5-fluorouracil Liver Cancer 4 263-273
[10]
Ma SQ(2016)The lack of Raf-1 kinase feedback regulation enhances antiapoptosis in cancer cells Oncogene 36 2014-2022